BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Sep 24, 2012
 |  BC Extra  |  Company News

Cytokinetics participating in MyoKardia launch

Cytokinetics Inc. (NASDAQ:CYTK) said it received an equity stake in new cardiovascular company MyoKardia Inc. (San Francisco, Calif.) in exchange for patent rights related to Cytokinetics' cardiac sarcomere...

Read the full 134 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >